Disease |
Disease |
Drug/chemo/stress |
Method |
Sample |
Expression pattern |
Dysfunction type |
Description |
PMID |
breast cancer |
|
knockdown |
breast cancer cells |
up-regulated |
interaction |
The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications. |
27780718 |
hepatocellular carcinoma |
|
qRT-PCR, knockdown, overexpression, ChiP, RIP, |
HCC tissues |
up-regulated |
interaction |
Long noncoding RNA 91H overexpression contributes to the growth and metastasis of HCC by epigenetically positively regulating IGF2 expression. |
31724285 |
colorectal cancer |
|
immunoprecipitation, RIP |
colorectal cancer |
up-regulated |
interaction |
lncRNA 91H promotes IGF2 expression by interacting with IGF2BP2 which would provide a new strategy in finding potential CRC diagnostic biomarkers and therapeutic targets. |
32070145 |
osteosarcoma |
|
Knockdown |
osteosarcoma patients and cell lines compared to healthy controls and normal human bone cell lines |
up-regulated |
expression |
High expression of 91H was significantly correlated with advanced clinical stage, chemotherapy after surgery, and tumor size >5 cm. Furthermore, 91H was an independent prognostic factor for overall survival in osteosarcoma patients after treatments. |
27555785 |
colorectal cancer |
|
|
CRC patients |
differential expression |
expression |
LncRNA 91H enhancing CRC metastasis by modifying HNRNPK expression might be an early plasma-based biomarker for CRC recurrence or metastasis. |
29410604 |